Received May 11, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | M4ZE7 | IM / RL |
Patient started with quarter sized erythematous rash to injection site on R thigh the night after receiving injection on 5/7/26. Patient rash continued to grow in size over the next two days. Patient was evaluated in clinic on 5/9/26, was told to take Benadryl OTC and use Benadryl lotion as needed and continue to monitor. Patient was evaluated in the ER on 5/10 for adverse reaction. Rash had grown to cover the child's entire thigh and was pruritic per patient's mother. Child was started on Clindamycin, with improvement noted the next day, 5/11/26. Patient evaluated in clinic 5/11/26 for follow up, rash much improved, quarter sized with minor pruritis noted.
None
None
None
None
Ultrasound performed in ER on 5/10- no abscess noted, some tissue edema.